Henry Schein, Inc.(HSIC)

$89.77—

Chart

Henry Schein, Inc.(HSIC)

NASDAQ

$89.77—

Chart Studio

HSIC(HSIC)

HSIC

Overview Stream Notebook Intel Chart History Fundamentals TTM Earnings Analysts News Financials Segments Insiders Institl.DCF Peers

Q4 2026 EPS Estimate

$1.35

Nov 3, 2026 · Reports before open

Revenue Estimate

$3.47B

FY2026E EPS$5.38

FY2027E EPS$6.00

Analyst Sentiment

Wall St. Consensus

Hold

33 analysts·High coverage

Score

17 Buy (52%)13 Hold (39%)3 Sell (9%)

Rating Breakdown

Strong Buy

00%

Buy

1752%

Hold

1339%

Sell

39%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear

$64.00

-28.7%

Consensus

$94.50

+5.3%

Bull

$104.00

+15.9%

12-Month Target Range33 analysts

$64.00$94.50$104.00

Current $89.77Consensus

Current Price

$89.77

Upside to Consensus

$4.73

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev+4.07%

EPS+11.46%

FY2028

Rev+4.03%

EPS+10.15%

FY2029

Rev+5.18%

EPS+5.60%

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Metric	FY2026E	FY2027E	FY2028E	FY2029E
Revenue Avg	$13.86B	$14.42B	$15.01B	$15.78B
Low	$13.85B	$14.37B	$14.78B	$15.69B
High	$13.87B	$14.52B	$15.38B	$15.97B
EBITDA Avg	$1.07B	$1.11B	$1.16B	$1.22B
Low	$1.07B	$1.11B	$1.14B	$1.21B
High	$1.07B	$1.12B	$1.18B	$1.23B
EBIT Avg	$788M	$820M	$853M	$897M
Low	$787M	$817M	$840M	$892M
High	$788M	$825M	$874M	$908M
Net Income Avg	$655M	$742M	$733M	$849M
Low	$644M	$708M	$719M	$842M
High	$666M	$777M	$877M	$862M
EPS Avg	$5.38	$6.00	$6.61	$6.97
Low	$5.29	$5.81	$5.91	$6.92
High	$5.47	$6.38	$7.21	$7.08
Analysts (Rev / EPS)	10 / 11	13 / 11	13 / 6	7 / 2

Quarterly

Metric	Q3 2026	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027	Q1 2028	Q2 2028
Revenue Avg	$3.47B	$3.56B	$3.49B	$3.58B	$3.62B	$3.72B	$3.63B	$3.72B
Low	$3.46B	$3.53B	$3.46B	$3.55B	$3.59B	$3.69B	$3.60B	$3.69B
High	$3.49B	$3.61B	$3.52B	$3.62B	$3.65B	$3.75B	$3.66B	$3.75B
EBITDA Avg	$267M	$274M	$269M	$276M	$279M	$286M	$280M	$287M
Low	$267M	$272M	$266M	$274M	$276M	$284M	$277M	$284M
High	$269M	$278M	$271M	$278M	$281M	$289M	$282M	$289M
EBIT Avg	$197M	$203M	$198M	$204M	$206M	$211M	$206M	$212M
Low	$197M	$201M	$197M	$202M	$204M	$210M	$205M	$210M
High	$199M	$205M	$200M	$206M	$207M	$213M	$208M	$213M
Net Income Avg	$155M	$165M	$164M	$164M	$171M	$183M	$186M	$187M
Low	$149M	$161M	$162M	$162M	$169M	$181M	$184M	$185M
High	$160M	$171M	$166M	$165M	$173M	$185M	$188M	$189M
EPS Avg	$1.36	$1.44	$1.44	$1.43	$1.49	$1.60	$1.63	$1.63
Low	$1.31	$1.41	$1.42	$1.41	$1.48	$1.58	$1.61	$1.61
High	$1.40	$1.49	$1.45	$1.45	$1.51	$1.62	$1.65	$1.65
Analysts (Rev / EPS)	10 / 12	10 / 11	6 / 9	6 / 4	6 / 4	6 / 7	5 / 5	5 / 5

Earnings Surprises

Recent Analyst Actions

Aug 6, 2026Barclays

Henry Schein price target raised to $100 from $86 at Barclays

Target:$100.00

+11.6%from $89.59

Aug 5, 2026Barrington

Henry Schein price target raised to $104 from $97 at Barrington

Target:$104.00

+16.7%from $89.11

Aug 5, 2026UBS

Henry Schein price target raised to $94 from $89 at UBS

Target:$94.00

+5.5%from $89.11

Aug 5, 2026Stifel Nicolaus

Henry Schein price target raised to $95 from $84 at Stifel

Target:$95.00

+6.6%from $89.11

Jul 28, 2026UBS

Henry Schein price target raised to $89 from $85 at UBS

Target:$89.00

+3.6%from $85.88

Jul 8, 2026BMO Capital

Henry Schein initiated with a Market Perform at BMO Capital

Target:$85.00

+2.1%from $83.22

Jun 11, 2026BTIG

BTIG upgrades Henry Schein to Buy on 'healthy' dental markets

Target:$100.00

+26.8%from $78.85

May 6, 2026UBS

Henry Schein price target lowered to $85 from $87 at UBS

Target:$85.00

+14.3%from $74.35

May 6, 2026Mizuho Securities

Henry Schein price target lowered to $82 from $88 at Mizuho

Target:$82.00

+10.3%from $74.37

May 6, 2026Robert W. Baird

Henry Schein price target lowered to $97 from $104 at Baird

Target:$97.00

+30.4%from $74.37

Apr 24, 2026Morgan Stanley

Henry Schein price target raised to $64 from $61 at Morgan Stanley

Target:$64.00

-18.2%from $78.22

Feb 25, 2026Barrington

Henry Schein price target raised to $97 from $79 at Barrington

Target:$97.00

+18.9%from $81.60

Feb 24, 2026Leerink Partners

Henry Schein price target raised to $87 from $75 at Leerink

Target:$87.00

+4.4%from $83.35

Feb 23, 2026Robert W. Baird

Henry Schein upgraded to Outperform from Neutral at Baird

Target:$100.00

+25.7%from $79.57

Jan 20, 2026Mizuho Securities

Henry Schein price target raised to $81 from $74 at Mizuho

Target:$81.00

+1.3%from $79.98

Dec 8, 2025Barclays

Henry Schein initiated with an Overweight at Barclays

Target:$86.00

+18.0%from $72.86

Nov 5, 2025Evercore ISI

Henry Schein price target raised to $90 from $83 at Evercore ISI

Target:$90.00

+25.5%from $71.69

Nov 5, 2025Barrington

Henry Schein price target raised to $79 from $78 at Barrington

Target:$79.00

+10.8%from $71.32

Aug 26, 2025Evercore ISI

Henry Schein upgraded to Outperform from In Line at Evercore ISI

Target:$83.00

+20.2%from $69.04

Jul 14, 2025Leerink Partners

Henry Schein price target raised to $75 from $69 at Leerink

Target:$75.00

+5.9%from $70.81

May 6, 2025Barrington

Henry Schein price target lowered to $86 from $90 at Barrington

Target:$86.00

+29.8%from $66.24

Oct 15, 2024CFRA

CFRA Downgrades Henry Schein (HSIC) to Sell ,'see better near-term upside in pharmaceutical distributors'

Target:$67.00

-5.8%from $71.10

Oct 8, 2024Evercore ISI

Henry Schein price target raised to $74 from $70 at Evercore ISI

Target:$74.00

+6.8%from $69.30

Jul 22, 2024Robert W. Baird

Baird Upgrades Henry Schein (HSIC) to Outperform

Target:$92.00

+30.8%from $70.34

Nov 13, 2023Stifel Nicolaus

Henry Schein Gears Up For Q3 Print; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts

Target:$70.00

+9.3%from $64.07

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance